Physician profile

Robert D Blute, JR.

Urology · Worcester, MA

NPI 1639178031

$2,069.39

in general payments reported to CMS, 2019-2025

17 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astellas Pharma US INC $907.16 2019-2022
Janssen Biotech, INC. $173.43 2019-2020
Abbvie INC. $161.81 2019-2020
Pfizer INC. $145.17 2019-2020
Dornier Medtech America, INC $127.25 2022
Procept Biorobotics Corporation $119.84 2022
Tolmar Pharmaceuticals, INC. $78.79 2019
Endo Pharmaceuticals INC. $70.27 2019-2021
Acerus Pharmaceuticals Corporation $58.91 2021-2022
Neotract INC. $56.36 2019-2020
Urogen Pharma, INC. $49.69 2021
Blue Earth Diagnostics $30.68 2019
Karl Storz Endoscopy-America $27.43 2019
Metuchen Pharmaceuticals $17.87 2019
Boston Scientific Corporation $15.61 2019
Show all 17 companies
CompanyGeneral paymentsYearsTop products
Allergan, INC. $15.38 2019
Sagent Pharmaceuticals $13.74 2019

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Robert D Blute, JR.

$2,069.39

in general payments reported 2019-2025

Years
2019-2022
Top company
Astellas Pharma US INC

https://glasscript.com/doctor/73721/robert-d-blute

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.